As the Food and Drug Administration prepares to review COVID-19 booster data from Johnson & Johnson and Moderna this week, other clinical trials are studying the potential of mixing doses of two different vaccines. Immunologist Dr. John Wherry joins CBSN to discuss why this is not yet a good idea.
